Status report
Get it in writing
The official USPTO status record for GETTING BETTER SOONER, serial 98693980, as a dated PDF. One price, one document, delivered in about a minute.
INSTANT DELIVERY
Trademark Status Report
$7.99
The USPTO's own status record for this mark, on one dated page.
- Current status with a plain-English verdict
- Owner, classes, filing basis, and every key date
- The mark as it appears on the federal record
- Every prosecution event, filing to today
- Source-cited with the exact retrieval date
Built from the USPTO's TSDR record. Assignment chain of title and TTAB proceeding files sit in separate USPTO systems and are not included.
Preview
◆ TRADEMARKCHECKER.AITRADEMARK STATUS REPORT
GETTING BETTER SOONERSerial 98693980 · Principal Register
Pending · Published for Opposition
Owner: Annexon, Inc.
Class 005 - Pharmaceuticals
Class 042 - Scientific & Technology Services
Class 044 - Medical & Beauty Services
Filed Aug 12, 2024
The record shows a live, pending application for the mark “GETTING BETTER SOONER” owned by Annexon, Inc., a Delaware corporation, and it is currently published for opposition as of November 10, 2026. The goods and services listed fall in three classes: Class 005 covers pharmaceutical preparations for treating a wide range of immune‑system, neurological, ophthalmic and other serious diseases; Class 042 includes pharmaceutical research and development, consulting, and the provision of medical and scientific research information; and Class 044 limits the mark to providing medical information related to pharmaceuticals. Because the listed scope is centered on high‑tech medical and pharmaceutical activities, a similar name used in those same fields would present the closest record‑based concern, while uses outside those areas are farther from the specific scope shown. The latest meaningful event is the publication for opposition on November 10, 2026, and the supplied history shows no oppositions, cancellations or other enforcement actions. I'd treat this as a meaningful concern if you plan to use the phrase in any pharmaceutical or medical‑research context.
Full event history, owner details, and verdict inside.
The way I'd use it, honestly, is as the thing you attach when a bank, a marketplace, or a co-founder asks "are we clear on the name". It answers in one page.